Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 13, 2000

View Archived Issues

PowderJect To Pay US$79.2M For Celltech's Vaccine Arm

Cureon To Develop Therapeutic Applications Of LNA Platform

Cell Therapy More Promising After Stem Cell Breakthrough

Peptor Diabetes Drug Looks Promising At Phase II Interim

European Parliament Condemns British Decision To Allow Cloning

Antisoma Harnesses Cyanide, Antibodies For Cancer Therapy

Medarex To Create Antibodies For OGS Proteomics Targets

IsoTis Gearing Up For Trials, October Stock Market Float

ExonHit Raises US$12M, Prepares For IPO In 2001

Biotie Targets Inflammation Protein With Dual Activity

Amrad Advances Clinical Slate, Including HBV, Pain Therapies

Other News To Note

Bionomics Seeking Partners For Cancer, Epilepsy Genes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.